NCT04603339

Brief Summary

Feasibility study of a 12-week multidisciplinary telehealth rehabilitation programme for survivors of upper gastrointestinal (UGI) cancer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 26, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

April 13, 2022

Status Verified

April 1, 2022

Enrollment Period

6 months

First QC Date

September 21, 2020

Last Update Submit

April 5, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Feasibility - Recruitment

    Feasibility will be determined by recruitment rate, the number of eligible participants who consent to participation.

    Through study completion approx 1 year

  • Feasibility - adherence

    Feasibility will also be determined by adherence to the trial intervention, the number of prescribed intervention sessions completed.

    From baseline (T0) to immediately after the program intervention (T1)

  • Feasibility - acceptability of the intervention (1)

    Feasibility will also be determined by the acceptability of the programme. Acceptability of the telehealth programme will be assessed by the Telehealth Usability Questionnaire (TUQ). The Telehealth Usability scale is a 5 point likert scale where 1 = completely disagree, and 5 =fully agree, Higher ratings indicate better usability.

    Immediately after the program intervention (T1)

  • Feasibility - acceptability of the intervention (2)

    Acceptability of the intervention will be further determined by a qualitative approach.Interviews will be carried out with participants post-intervention to gain their perspectives of the impact of the program on physical and mental well-being and the suitability of the programme to delivery via telehealth

    Duration of the trial i.e. From enrolment of the first participant until completion of the final participants post-intervention assessment (Time period of up to 12 months).

Secondary Outcomes (12)

  • Change in Cardiorespiratory Fitness from Baseline

    Baseline (T0), Immediately after the program intervention (T1)

  • Physical Performance

    Baseline (T0), Immediately after the program intervention (T1)

  • Hand Grip Strength

    Baseline (T0), Immediately after the program intervention (T1)

  • Physical Activity

    Baseline (T0), Immediately after the program intervention (T1)

  • Weight

    Baseline (T0), Immediately after the program intervention (T1)

  • +7 more secondary outcomes

Study Arms (1)

Intervention Arm

EXPERIMENTAL

Single arm trial, all participants will receive the intervention

Other: Multidisciplinary rehabilitation programme delivered via telehealth

Interventions

12 week programme of; 1\) Physiotherapy led aerobic and resistance exercise 2)1:1 Dietetics Counselling 3) Group Multidisciplinary Education Sessions

Intervention Arm

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be ≥ three months post oesophagectomy, total gastrectomy
  • ± neo-adjuvant/adjuvant chemo/chemoradiotherapy with curative intent
  • adjuvant therapy must be completed
  • access to home broadband

You may not qualify if:

  • Ongoing serious post-operative morbidity
  • Evidence of active or recurrent disease.
  • In addition those with any serious co-morbidity that would impact on exercise participation will be excluded including those with;
  • Uncontrolled hypertension (resting systolic blood pressure \>180mmHg and/or diastolic \>100mmHg)
  • Recent serious cardiovascular events (within 12 months) including, but not limited to cerebrovascular accident, and myocardial infarction
  • Unstable cardiac, renal, lung, liver or other severe chronic disease
  • Uncontrolled atrial fibrillation
  • Left ventricular function \<50%.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Trinity College Dublin

Dublin, Leinster, Ireland

Location

Related Publications (1)

  • O'Neill L, Guinan E, Brennan L, Doyle SL, O'Connor L, Sheill G, Smyth E, Fairman CM, Segurado R, Connolly D, O'Sullivan J, Reynolds JV, Hussey J. ReStOre@Home: Feasibility study of a virtually delivered 12-week multidisciplinary rehabilitation programme for survivors of upper gastrointestinal (UGI) cancer - study protocol. HRB Open Res. 2021 May 4;3:86. doi: 10.12688/hrbopenres.13185.2. eCollection 2020.

MeSH Terms

Conditions

Esophageal NeoplasmsStomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesStomach Diseases

Study Officials

  • Juliette Hussey, PhD

    University of Dublin, Trinity College

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single arm feasibility study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Physiotherapy

Study Record Dates

First Submitted

September 21, 2020

First Posted

October 26, 2020

Study Start

May 1, 2021

Primary Completion

October 30, 2021

Study Completion

January 1, 2022

Last Updated

April 13, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations